Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia

Xia Huang1, Yingying Luo1, Jing Wang1

  • 1Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.

Respiratory Research
|January 18, 2024
PubMed
Abstract

Insights

In children, complicated Mycoplasma pneumoniae pneumonia (MPP) shows a disrupted lung microbiome. Interactions between the pathogen, lung microbiome, and host response impact MPP severity and recovery.

Area of Science:

  • Pediatric Respiratory Medicine
  • Microbiome Research
  • Immunology

Background:

  • Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory infection.
  • Understanding the interplay between pathogen, lung microbiome, and host response is crucial for managing MPP.
  • Distinct clinical presentations, general MPP (GMPP) and complicated MPP (CMPP), suggest underlying biological differences.

Purpose of the Study:

  • To investigate the interactions among pathogen, lung microbiome, and host response in pediatric MPP.
  • To correlate these interactions with disease severity and clinical outcomes.
  • To differentiate these elements between general and complicated forms of MPP.

Main Methods:

  • Prospective collection of bronchoalveolar lavage fluid from 41 children with MPP.
  • Microbiome and transcriptomic analyses of lung fluid.
  • Correlation of findings with clinical features and outcomes, distinguishing between GMPP and CMPP.

Main Results:

  • Complicated MPP (CMPP) exhibited an increased relative abundance of Mycoplasma pneumoniae (MP) and reduced lung microbiome diversity.
  • Host gene analysis identified key modules related to neutrophil function and inflammatory pathways.
  • A specific lung microbiome and host response profile associated with high MP abundance correlated with CMPP and prolonged imaging recovery.

Conclusions:

  • Patients with CMPP present with a more disrupted lung microbiome compared to GMPP.
  • Interactions between MP, the lung microbiome, and host response are intrinsically linked to MPP severity and outcomes in children.
  • These findings highlight potential therapeutic targets for improving pediatric MPP management.